Global Oral Anti-Diabetic Drug Market Report By Product (Sulfonylureas, Biguanides, Alpha-Glucosidase Inhibitors, Megalitinides And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210389
January 2019
Report Formats:

As per this study, the Global Oral Anti-Diabetic Drug Market was valued USD 24.2 BN (by revenue) in 2018 and is anticipated to reach USD 47.2 BN by 2025 with a CAGR of 10%.

Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.

Market Dynamics
 
Rising diabetic patients globally are majorly driving the demand for oral anti-diabetic drugs. Poor eating habits, stressful lifestyle and lack of physical exercise are some of the factors key contributor in the market growth. Rising demand for oral drugs to reduce blood sugar level owing to a convenient alternative to insulin injections are further fueling the market growth. Advancement in technology leading to development of efficient drugs to minimize the rate of diabetes among the population is expected to boost the market. However, the high cost of drugs is expected to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of oral anti-diabetic drug.
 
Market Segmentation
 
The broad oral anti-diabetic drug market has been sub-grouped into the product. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • Sulfonylureas
    • Glimepiride
    • Gliclazide
    • Glyburide
    • Others
  • Biguanides
    • Metformin
    • Others
  • Alpha-Glucosidase Inhibitors
    • Acarbose
    • Voglibose
    • Others
  • Megalitinides
    • Repaglinide
    • Netaglinide
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for oral anti-diabetic drug in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Oral Anti-Diabetic Drug Market By Revenue (USD MN)
 
Europe Oral Anti-Diabetic Drug Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the oral anti-diabetic drug market include Abbott, AstraZeneca, Biocon, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Oral Anti-Diabetic Drug
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Oral Anti-Diabetic Drug Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. ORAL ANTI-DIABETIC DRUG MARKET ANALYSIS BY PRODUCT
  • Market In Sulfonylureas
    • Market In Glimepiride
    • Market In Gliclazide
    • Market In Glyburide
    • Market In Others
  • Market In Biguanides
    • Market In Metformin
    • Market In Others
  • Market In Alpha-Glucosidase Inhibitors
    • Market In Acarbose
    • Market In Voglibose
    • Market In Others
  • Market In Megalitinides
    • Market In Repaglinide
    • Market In Netaglinide
  • Market In Others
 
5. ORAL ANTI-DIABETIC DRUG MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
6. COMPETITIVE LANDSCAPE OF THE ORAL ANTI-DIABETIC DRUG COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
7. COMPANY PROFILES OF THE ORAL ANTI-DIABETIC DRUG INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Abbott
  • AstraZeneca
  • Biocon
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi 
  • Sun Pharmaceutical Industries Ltd.
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Oral Anti-Diabetic Drug
Table 2.  Global Oral Anti-Diabetic Drug Market By Product
Table 3.  Global Oral Anti-Diabetic Drug Market By Geography
Table 4.  North America Oral Anti-Diabetic Drug Market
Table 5.  Europe Oral Anti-Diabetic Drug Market
Table 6.  Asia Pacific Oral Anti-Diabetic Drug Market
Table 7.  Latin America Oral Anti-Diabetic Drug Market
Table 8.  Middle East And Africa Oral Anti-Diabetic Drug Market 
Table 9.  Partnership/Collaboration/Agreements
Table 10. Mergers And Acquisitions
Table 11. New Product Development
Table 12. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Oral Anti-Diabetic Drug Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Oral Anti-Diabetic Drug
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Oral Anti-Diabetic Drug Market By Product
Fig. 8.     Global Oral Anti-Diabetic Drug Market By Geography
Fig. 9.     North America Oral Anti-Diabetic Drug Market
Fig. 10.   Europe Oral Anti-Diabetic Drug Market
Fig. 11.   Asia Pacific Oral Anti-Diabetic Drug Market
Fig. 12.   Latin America Oral Anti-Diabetic Drug Market
Fig. 13.   Middle East And Africa Oral Anti-Diabetic Drug Market
Fig. 14.   Market Share Of Oral Anti-Diabetic Drug Companies
Fig. 15.   Recent Developments In Oral Anti-Diabetic Drug Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC. 

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials